United States 115th Congress Status: Died 1 R cosponsors

HR 7217 — IMPROVE Act Improving Medicaid Programs and Opportunities for Eligible Beneficiaries Act

Last action — Received in the Senate.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. Died in session

This bill died with 115th Congress. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

IMPROVE Act Improving Medicaid Programs and Opportunities for Eligible Beneficiaries Act This bill establishes a state Medicaid option to provide for medical assistance with respect to coordinated care provided through a health home (i.e., a designated provider or team of health-care professionals) for children with medically complex conditions. States must determine payment methodologies in accordance with specified requirements; payments also temporarily qualify for an enhanced federal matching rate. The bill also makes a series of reductions relating to federal Medicaid expenditures. Among other changes, the bill reduces the federal matching rate for states that do not have required asset-verification programs for determining Medicaid eligibility. Further, drug manufacturers with Medicaid rebate agreements for covered outpatient drugs must disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly). Finally, the bill excludes specified wheelchairs and associated accessories from Medicare's competitive acquisition program (in which rates are set through a competitive bidding program rather than by an established fee schedule).

Bill Text

We don't have the full text on file for this bill yet.

Read HR 7217 on the official United States source →

Action History

  1. Received in the Senate.

  2. Motion to reconsider laid on the table Agreed to without objection.

  3. On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 400 - 11 (Roll no. 428). (text: H10043-10047)

  4. Considered as unfinished business. (consideration: H10043-10052)

  5. At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

  6. DEBATE - The House proceeded with forty minutes of debate on H.R. 7217.

  7. Considered under suspension of the rules.

  8. Mr. Barton moved to suspend the rules and pass the bill.

  9. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  10. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  11. Introduced in House

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Health Birth defects Blood and blood diseases Business records Cardiovascular and respiratory health Child health Civil actions and liability Disability and paralysis Emergency medical services and trauma care Family services HIV/AIDS Health care costs and insurance Health care coverage and access Health care quality Health personnel Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Hereditary and development disorders Home and outpatient care Hospital care Inflation and prices Long-term, rehabilitative, and terminal care Marriage and family status Medicaid Medical education Medicare Mental health Musculoskeletal and skin diseases Neurological disorders Prescription drugs Sex and reproductive health State and local courts State and local finance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 7217 do?
IMPROVE Act Improving Medicaid Programs and Opportunities for Eligible Beneficiaries Act This bill establishes a state Medicaid option to provide for medical assistance with respect to coordinated care provided through a health home (i.e., a designated provider or team of health-care professionals) for children with medically complex conditions. States must determine payment methodologies in accordance with specified requirements; payments also temporarily qualify for an enhanced federal matching rate. The bill also makes a series of reductions relating to federal Medicaid expenditures. Among other changes, the bill reduces the federal matching rate for states that do not have required asset-verification programs for determining Medicaid eligibility. Further, drug manufacturers with Medicaid rebate agreements for covered outpatient drugs must disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly). Finally, the bill excludes specified wheelchairs and associated accessories from Medicare's competitive acquisition program (in which rates are set through a competitive bidding program rather than by an established fee schedule).
Who sponsors HR 7217?
HR 7217 is sponsored by Joe Barton (R).
What is the current status of HR 7217?
This bill died with 115th Congress. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HR 7217?
Track HR 7217 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 7217

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 7217

Last checked for changes about 16 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →